Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Eur J Endocrinol ; 170(1): 77-85, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24114432

RESUMEN

BACKGROUND: We sought to investigate right ventricular (RV) function and deformation assessed by three-dimensional echocardiography (3DE) and speckle tracking in patients with subclinical hypothyroidism (SHT), and to evaluate the influence of levothyroxine (L-T4) therapy on RV remodeling. METHODS: We included 50 untreated women with SHT and 45 healthy control women matched by age. The L-T4 therapy was prescribed to all SHT patients who were followed 1 year after euthyroid status was achieved. All study participants underwent laboratory analyses which included thyroid hormone levels, and complete two-dimensional echocardiography (2DE) and 3DE examinations. RESULTS: 3DE RV end-diastolic volume and ejection fraction were significantly reduced in the SHT patients before therapy in comparison with the healthy controls and treated SHT subjects. RV longitudinal strain, systolic, and early diastolic strain rates (SRs) were significantly decreased, whereas RV late diastolic SR was increased in the SHT patients before therapy when comparing with the controls. 2DE speckle tracking imaging revealed that L-T4 substitution therapy significantly improved RV systolic mechanics, whereas RV diastolic deformation was not completely recovered. Right atrial (RA) function and deformation were significantly impacted by SHT. Replacement L-T4 treatment improved but did not completely restore RA mechanics in the SHT patients. CONCLUSION: RV and RA function and mechanics are significantly affected by SHT. L-T4 therapy and 1-year maintenance of euthyroid status improved but did not completely recover RV and RA function and deformation in the SHT patients, which implies that right heart remodeling caused by SHT is not reversible in a 1-year period.


Asunto(s)
Remodelación Atrial/efectos de los fármacos , Cardiopatías/prevención & control , Terapia de Reemplazo de Hormonas , Hipotiroidismo/tratamiento farmacológico , Tiroxina/uso terapéutico , Disfunción Ventricular Derecha/prevención & control , Remodelación Ventricular/efectos de los fármacos , Adulto , Función del Atrio Derecho/efectos de los fármacos , Volumen Cardíaco/efectos de los fármacos , Ecocardiografía Doppler de Pulso/efectos de los fármacos , Ecocardiografía Tridimensional/efectos de los fármacos , Femenino , Estudios de Seguimiento , Corazón/efectos de los fármacos , Corazón/fisiopatología , Cardiopatías/diagnóstico por imagen , Cardiopatías/etiología , Humanos , Hipotiroidismo/sangre , Hipotiroidismo/etiología , Hipotiroidismo/fisiopatología , Volumen Sistólico/efectos de los fármacos , Hormonas Tiroideas/sangre , Tiroiditis Autoinmune/fisiopatología , Tiroxina/sangre , Disfunción Ventricular Derecha/diagnóstico por imagen , Disfunción Ventricular Derecha/etiología , Función Ventricular Derecha/efectos de los fármacos
2.
Z Geburtshilfe Neonatol ; 203(1): 18-23, 1999.
Artículo en Alemán | MEDLINE | ID: mdl-10427668

RESUMEN

A prospective randomized double-blind study of low-dose aspirin treatment (100 mg/d) was conducted on a population of 43 pregnant women at risk of pregnancy-induced hypertension, preeclampsia, intrauterine growth retardation. Doppler ultrasound blood flow measurements of the uterine arteries and the umbilical cord, at the fetal and placental end, were obtained on a two-weekly interval in between 18 to 40 weeks of gestation. During the course of pregnancy Doppler indices of both vessels decreased, whereas the absolute velocity of the uterine arteries increased. Perfusion of both vessels did not show any relevant differences in between the aspirin- and placebo-group. Both groups showed a similar median duration of gestation at time of delivery (278 d aspirin vs. 270 d placebo). Comparison of median birthweight (3152.5 g aspirin vs. 2900 g placebo) did not show any significant difference. There were no haemodynamic effects of low-dose aspirin on the utero- and fetoplacental circulation to be demonstrated.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Aspirina/administración & dosificación , Ecocardiografía Doppler de Pulso/efectos de los fármacos , Retardo del Crecimiento Fetal/tratamiento farmacológico , Placenta/irrigación sanguínea , Ultrasonografía Prenatal/efectos de los fármacos , Útero/irrigación sanguínea , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Retardo del Crecimiento Fetal/diagnóstico por imagen , Edad Gestacional , Humanos , Recién Nacido , Masculino , Embarazo , Embarazo de Alto Riesgo , Estudios Prospectivos , Flujo Pulsátil/efectos de los fármacos , Flujo Sanguíneo Regional/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...